Co-morbidities

June 16, 2017
Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study
Summary Objectives In Belgium, eleven AIDS Reference Centers (ARCs) and seven AIDS Reference Laboratories diagnose and treat HIV-positive individuals and track patients under care. As AIDS-related deaths are avoided and the HIV-positive population ages, non-infectious comorbidities (NICMs), such as cardiovascular disease, renal disease and certain cancers, play a larger role in the quality and length […]

Read More
February 25, 2016
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Summary Background At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV–HCV co-infection. We sought to characterise the epidemiology and burden of HCV co-infection in people living with HIV. Methods In this systematic review and […]

Read More
October 1, 2013
Hepatitis C medicines and diagnostics in the context of HIV/HCV co-infection: A scoping report
Summary The UNITAID 2013-2016 Strategy includes the treatment of HIV/AIDS and co-infections as one of six strategic objectives. This scoping report focuses on issues, challenges and opportunities related to one of the most important HIV co-infections—Hepatitis C virus (HCV)—and represents UNITAID’s first effort to gather market intelligence on products for the diagnosis and treatment of […]

Read More

English